This literature review is focused on the prostaglandin topical analogues and describes peculiarities of their structure, pharmacokinetics and pharmacodynamics, results of clinical trials and meta-analyzes, as well as modern trends in the topical IOP-lowering glaucoma therapy evolution
Glaucoma affecting 60 million people all over the world and it will be 80 million till 2020. There a...
. Purpose. To compare the ocular hypotensive effect of tafluprost with prostaglandin analogues (PGAs...
Viran Jayanetti,1 Sartaj Sandhu,2 Jed A Lusthaus3 1Prince of Wales Hospital, Sydney, New South Wales...
Prostaglandin F2α analogues are the most recent class of ocular hypotensive drugs that have become a...
The history of glaucoma pharmacology begins in 1862 with the isolation of physostigmine from the cal...
Prostaglandin (PG)-related ophthalmic solutions, which only recently became available for clinical u...
The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) report...
The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) report...
PurposeThis study aimed to review previous articles and evaluate the influence of topical non-steroi...
Objective: The objective of this study was to assess the intraocular pressure (IOP)-lowering efficac...
The present invention relates to new prostaglandin derivatives having improved pharmacological activ...
Prostaglandin analogues are a class of antihypertensive drugs for glaucoma treatment which are syste...
International audienceGlaucoma is a wide-spread eye disease caused by elevated intraocular pressure....
Elevated intraocular pressure (IOP) has been recognized as the major risk factor for the development...
Elevated intraocular pressure (IOP) has been recognized as the major risk factor for the development...
Glaucoma affecting 60 million people all over the world and it will be 80 million till 2020. There a...
. Purpose. To compare the ocular hypotensive effect of tafluprost with prostaglandin analogues (PGAs...
Viran Jayanetti,1 Sartaj Sandhu,2 Jed A Lusthaus3 1Prince of Wales Hospital, Sydney, New South Wales...
Prostaglandin F2α analogues are the most recent class of ocular hypotensive drugs that have become a...
The history of glaucoma pharmacology begins in 1862 with the isolation of physostigmine from the cal...
Prostaglandin (PG)-related ophthalmic solutions, which only recently became available for clinical u...
The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) report...
The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) report...
PurposeThis study aimed to review previous articles and evaluate the influence of topical non-steroi...
Objective: The objective of this study was to assess the intraocular pressure (IOP)-lowering efficac...
The present invention relates to new prostaglandin derivatives having improved pharmacological activ...
Prostaglandin analogues are a class of antihypertensive drugs for glaucoma treatment which are syste...
International audienceGlaucoma is a wide-spread eye disease caused by elevated intraocular pressure....
Elevated intraocular pressure (IOP) has been recognized as the major risk factor for the development...
Elevated intraocular pressure (IOP) has been recognized as the major risk factor for the development...
Glaucoma affecting 60 million people all over the world and it will be 80 million till 2020. There a...
. Purpose. To compare the ocular hypotensive effect of tafluprost with prostaglandin analogues (PGAs...
Viran Jayanetti,1 Sartaj Sandhu,2 Jed A Lusthaus3 1Prince of Wales Hospital, Sydney, New South Wales...
DOI
Add to ORKG